Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion type Assertion NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_head.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion description "[ZNF342 expression is specifically decreased in primary oligodendrogliomas and up-regulated in glioma cell lines treated with a demethylating agent, whereas the expression level of the adjacent gene, Gemin7, is not consistently altered in these samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_provenance.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion evidence source_evidence_literature NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_provenance.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion SIO_000772 14633674 NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_provenance.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion wasDerivedFrom befree-2016 NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_provenance.
- NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_assertion wasGeneratedBy ECO_0000203 NP421642.RApvg7fFhuqoPH6M4lQ9aAcZL2fbKRY64OXbnaJy5L__s130_provenance.